Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug interaction study of TS-142 with itraconazole in healthy adults
jRCT2071200036Phase 1Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vornorexant in Insomnia, sponsored by Taisho Pharmaceutical. Primary endpoint: Plasma concentration of TS-142 (pharmacokinetics). Started Oct 2020; status: completed.
02
Drugs
vornorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCT2071200036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200036.